|
|
|
CORTISOL SIGNALING PATHWAY (PW:0000569)
DescriptionGlucocorticoid steroid hormones, cortisol in humans, play essential roles in the regulation of immune responses, metabolism, development as well as cognitive processes. Cortisol promotes the expression of anti-inflammatory proteins while repressing the expression of pro-inflammatory ones, stimulates gluconeogenesis in liver and the breakdown of fat in the adipose tissue. The synthesis of cortisol is under the control of the hypothalamus-pituitary-adrenal (HPA) axis. In response to various stresses, the hypothalamus releases corticotropin-releasing hormone (CRH) whose signaling results in activation of protein kinase A (PKA) pathway and the expression and release of pro-opiomelanocortin (POMC) gene from the pituitary. Processing of POMC gives rise to several peptides of which adrenocorticotropin (ACTH), specifically binding to melanocortin receptor type 2 (Mc2r) also setting in motion PKA, prompts the expression of steroidogenic genes and the secretion of cortisol from the adrenal cortex. Cortisol binds the glucocorticoid receptor Nr3c1, a nuclear hormone receptor. In the absence of ligand Nr3c1 is predominantly cytoplasmic and dynamically complexed with a chaperone/co-chaperone machinery that is critical for its function and turnover. Like the other members of the nuclear receptor superfamily, Nr3c1 is modular consisting of trans-activation, DNA-binding (DBD) and ligand-binding (LBD) domains. The N-terminal trans-activation domain 1 (AF-1) is ligand independent whereas a second domain (AF-2), embedded in the LBD, is ligand dependent. The DBD, which contains two zinc fingers motifs, is the most conserved domain within the family. Two main receptor isoforms are generated through alternative splicing of which the alpha represents the classic glucocorticoid receptor. The beta isoform, thought to be largely disordered, does not bind glucocorticoids and while residing in the nucleus does not regulate gene expression. Yet, if co-expressed with the alpha isoform, it can act as an inhibitor of the classic receptor, suggesting a possible modulator role. Additional splice and translational isoforms have been reported. Upon ligand binding, Nr3c1 translocates to the nucleus where it binds as a homodimer to specific glucocorticoids response elements (GRE) or, possibly as a monomer, to other transcription factors to enhance or downregulate the transcription of many genes. The receptor may bind negative GRE as another mechanism of repression. In addition, Nr3c1 interacts with many coactivators and corepressors that modulate the outcomes of its function. Nr3c1is a substrate for many post-translational modifications that affect in various ways its function and fate. The receptor plays important roles in the negative feedback loop the pathway provides for the upstream components of the HPA axis. A notable example is the repression of POMC gene expression. While POMC, and also CRH genes appear to harbor negative GREs, Nr3c1 has been reported to bind to and antagonize the function of Nr4a1, an orphan nuclear receptor and transcriptional mediator of POMC expression. The Nr3c1 coactivator Brg1 is crucial for the interaction; the complex can then recruit Hdac2 and silence gene expression. Glucocorticoid deficiency or excess has been associated with several pathophysiological conditions. To see the ontology report for annotations, GViewer and downloads, click here...(less)
|
Pathway Diagram:
|
|
|
Genes in Pathway:
cortisol signaling pathway
|
| G |
Crebbp |
CREB binding protein |
|
|
ISS |
10 |
11,598,680 |
11,724,122 |
RGD:5147892 |
RGD |
| G |
Dnaja2 |
DnaJ (Hsp40) homolog, subfamily A, member 2 |
|
|
ISS |
19 |
22,853,702 |
22,871,846 |
RGD:5144125 |
RGD |
| G |
Ep300 |
E1A binding protein p300 |
|
|
ISS |
7 |
119,938,507 |
120,008,886 |
RGD:5147892 |
RGD |
| G |
Fkbp4 |
FK506 binding protein 4 |
|
|
ISS |
4 |
165,448,027 |
165,456,481 |
RGD:5144125 |
RGD |
| G |
Fkbp5 |
FK506 binding protein 5 |
|
|
ISS |
20 |
6,637,478 |
6,686,768 |
RGD:5144125 |
RGD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
|
ISS |
6 |
135,413,616 |
135,419,147 |
RGD:5144125 |
RGD |
| G |
Hsp90ab1 |
heat shock protein 90 alpha (cytosolic), class B member 1 |
|
|
ISS |
9 |
11,033,496 |
11,038,868 |
RGD:5144125 |
RGD |
| G |
Hspa4 |
heat shock protein 4 |
|
|
ISS |
10 |
38,705,629 |
38,749,058 |
RGD:5144125 |
RGD |
| G |
Med1 |
mediator complex subunit 1 |
|
|
ISS |
10 |
86,917,525 |
86,959,080 |
RGD:5147892 |
RGD |
| G |
Med1 |
mediator complex subunit 1 |
|
|
TAS |
10 |
86,917,525 |
86,959,080 |
RGD:5147892 |
RGD |
| G |
Med14 |
mediator complex subunit 14 |
|
|
ISS |
X |
22,116,986 |
22,205,877 |
RGD:5147892 |
RGD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
|
ISS |
6 |
27,224,396 |
27,473,926 |
RGD:5144138 |
RGD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
|
ISS |
6 |
27,224,396 |
27,473,926 |
RGD:5147892 |
RGD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
|
ISS |
5 |
5,197,891 |
5,275,776 |
RGD:5144138 |
RGD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
|
ISS |
5 |
5,197,891 |
5,275,776 |
RGD:5147892 |
RGD |
| G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
|
ISS |
3 |
157,168,492 |
157,196,566 |
RGD:5144138 |
RGD |
| G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
|
ISS |
3 |
157,168,492 |
157,196,566 |
RGD:5147892 |
RGD |
| G |
Ncor1 |
nuclear receptor co-repressor 1 |
|
|
ISS |
10 |
48,481,110 |
48,628,538 |
RGD:5147413 |
RGD |
| G |
Ncor2 |
nuclear receptor co-repressor 2 |
|
|
ISS |
12 |
32,617,643 |
32,725,753 |
RGD:5147413 |
RGD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
|
ISS |
18 |
32,371,496 |
32,459,145 |
RGD:5144125 |
RGD |
| G |
Ptges3 |
prostaglandin E synthase 3 (cytosolic) |
|
|
ISS |
7 |
1,351,206 |
1,368,857 |
RGD:5144125 |
RGD |
| G |
Smarca4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
|
|
ISS |
8 |
20,720,915 |
20,812,157 |
RGD:5147892 |
RGD |
| G |
Stip1 |
stress-induced phosphoprotein 1 |
|
|
ISS |
1 |
209,693,427 |
209,712,779 |
RGD:5144125 |
RGD |
|
|
|
Pathway Gene Annotations |
|
Disease Annotations Associated with Genes in the cortisol signaling pathway
|
|
|
|
| Crebbp | Leukemia, Myeloid, Acute , Rubinstein-Taybi Syndrome | | Dnaja2 | Liver Diseases | | Ep300 | Breast Neoplasms , Carcinoma, Hepatocellular , Colorectal Neoplasms , Diabetes Mellitus, Experimental , Heart Arrest , Heart Diseases , Hypertension , Hypoxia, Brain , Prostatic Neoplasms , Rubinstein-Taybi Syndrome | |
| Fkbp5 | Depressive Disorder, Major | | Hsp90aa1 | Breast Neoplasms , Diabetes Mellitus, Experimental , Hypertension, Portal | | Hsp90ab1 | Multiple Sclerosis , Muscular Atrophy , Pancreatitis | | Hspa4 | Arthritis, Rheumatoid , Brain Injuries , Chagas Disease , Colitis, Ulcerative , Diabetes Mellitus, Type 2 , Dry Eye Syndromes , Heat Stroke , Infarction, Middle Cerebral Artery , Liver Neoplasms , Neurodegenerative Diseases , Parkinson Disease , Pulmonary Disease, Chronic Obstructive , Respiratory Distress Syndrome, Adult , Spinal Cord Compression | |
|
| Ncoa1 | Breast Neoplasms , Endometrial Neoplasms , Hypothyroidism , Prostatic Neoplasms | | Ncoa2 | Pregnancy Complications , Prostatic Neoplasms | | Ncoa3 | Breast Neoplasms , Obesity , Prostatic Neoplasms | | Ncor1 | Huntington Disease , Hypothyroidism , Polycystic Ovary Syndrome | | Ncor2 | Breast Neoplasms , Endometrial Neoplasms , Osteoarthritis | | Nr3c1 | Anorexia Nervosa , Arthritis, Rheumatoid , Asthma , Brain Ischemia , Burns , Carcinoma, Renal Cell , Cataract , Coronary Artery Disease , Cushing Syndrome , Depressive Disorder , Depressive Disorder, Major , Diabetes Mellitus, Type 2 , Disorders of Sex Development , Edema , Encephalomyelitis, Autoimmune, Experimental , Endotoxemia , Epilepsy, Temporal Lobe , Fetal Growth Retardation , Heart Failure , Hypertension , Kidney Failure, Chronic , Liver Cirrhosis, Biliary , Lung Diseases , Lung Diseases, Interstitial , Lupus Nephritis , Malocclusion , Muscular Atrophy , Nephrosis, Lipoid , Nephrotic Syndrome , Nephrotic syndrome, idiopathic, steroid-resistant , Obesity , Polycystic Ovary Syndrome , Pulmonary Disease, Chronic Obstructive , Rhinitis, Allergic, Perennial , Sarcoidosis, Pulmonary , Seizures , Sepsis , Sinusitis , Sleep Apnea, Obstructive , Stress Disorders, Post-Traumatic , Stroke , Transplant Rejection , Uveitis | | Ptges3 | Arthritis, Experimental , Atherosclerosis , Breast Neoplasms , Hyperalgesia , Oligodendroglioma | | Smarca4 | Lung Neoplasms , Prostatic Neoplasms , Rhabdoid Tumor Predisposition Syndrome 2 | |
|
| Rubinstein-Taybi Syndrome | Crebbp , Ep300 | | Cataract | Nr3c1 | | Fetal Growth Retardation | Nr3c1 | | Carcinoma, Renal Cell | Nr3c1 | | Obesity | Nr3c1 , Ncoa3 | | Seizures | Nr3c1 | | Diabetes Mellitus, Type 2 | Hspa4 , Nr3c1 | | Liver Neoplasms | Hspa4 | | Pregnancy Complications | Ncoa2 | | Lung Neoplasms | Smarca4 | | Hypothyroidism | Ncoa1 , Ncor1 | | Osteoarthritis | Ncor2 | | Neurodegenerative Diseases | Hspa4 | | Nephrotic Syndrome | Nr3c1 | | Breast Neoplasms | Ep300 , Ncoa3 , Hsp90aa1 , Ncoa1 , Ncor2 , Ptges3 | | Nephrosis, Lipoid | Nr3c1 | | Lung Diseases | Nr3c1 | | Sinusitis | Nr3c1 | | Colitis, Ulcerative | Hspa4 | | Liver Diseases | Dnaja2 | | Kidney Failure, Chronic | Nr3c1 | | Nephrotic syndrome, idiopathic, steroid-resistant | Nr3c1 | | Muscular Atrophy | Hsp90ab1 , Nr3c1 | | Disorders of Sex Development | Nr3c1 | | Arthritis, Rheumatoid | Hspa4 , Nr3c1 | | Huntington Disease | Ncor1 | | Uveitis | Nr3c1 | | Colorectal Neoplasms | Ep300 | | Epilepsy, Temporal Lobe | Nr3c1 | | Hypertension | Nr3c1 , Ep300 | | Parkinson Disease | Hspa4 | | Prostatic Neoplasms | Ep300 , Ncoa2 , Ncoa3 , Smarca4 , Ncoa1 | | Carcinoma, Hepatocellular | Ep300 | | Edema | Nr3c1 | | Polycystic Ovary Syndrome | Ncor1 , Nr3c1 | | Hypertension, Portal | Hsp90aa1 | | Liver Cirrhosis, Biliary | Nr3c1 | | Lung Diseases, Interstitial | Nr3c1 | | Anorexia Nervosa | Nr3c1 | | Heart Diseases | Ep300 | | Arthritis, Experimental | Ptges3 | | Asthma | Nr3c1 | | Brain Injuries | Hspa4 | | Burns | Nr3c1 | | Hypoxia, Brain | Ep300 | | Brain Ischemia | Nr3c1 | | Chagas Disease | Hspa4 | | Coronary Artery Disease | Nr3c1 | | Cushing Syndrome | Nr3c1 | | Malocclusion | Nr3c1 | | Depressive Disorder, Major | Fkbp5 , Nr3c1 | | Depressive Disorder | Nr3c1 | | Diabetes Mellitus, Experimental | Ep300 , Hsp90aa1 | | Heart Failure | Nr3c1 | | Encephalomyelitis, Autoimmune, Experimental | Nr3c1 | | Leukemia, Myeloid, Acute | Crebbp | | Heart Arrest | Ep300 | | Hyperalgesia | Ptges3 | | Dry Eye Syndromes | Hspa4 | | Lupus Nephritis | Nr3c1 | | Multiple Sclerosis | Hsp90ab1 | | Oligodendroglioma | Ptges3 | | Pancreatitis | Hsp90ab1 | | Sleep Apnea, Obstructive | Nr3c1 | | Respiratory Distress Syndrome, Adult | Hspa4 | | Rhinitis, Allergic, Perennial | Nr3c1 | | Sepsis | Nr3c1 | | Spinal Cord Compression | Hspa4 | | Stress Disorders, Post-Traumatic | Nr3c1 | | Heat Stroke | Hspa4 | | Endometrial Neoplasms | Ncoa1 , Ncor2 | | Sarcoidosis, Pulmonary | Nr3c1 | | Endotoxemia | Nr3c1 | | Infarction, Middle Cerebral Artery | Hspa4 | | Stroke | Nr3c1 | | Pulmonary Disease, Chronic Obstructive | Nr3c1 , Hspa4 | | Atherosclerosis | Ptges3 | | Rhabdoid Tumor Predisposition Syndrome 2 | Smarca4 | | Transplant Rejection | Nr3c1 | |
|